There is a chance that peptides besides GLP-1s will eventually be demonstrated to provide health outcome benefits as seen in rodent pre-clinical models
Insulin-like growth factor-1, as discussed earlier, has implications on lipid and glucose metabolism [87, 88], and its exogenous administration enhances insulin sensitivity in healthy adults [139, 140] as well as those with T2D [155]
These medications are vasodilators, which increase blood flow and lower blood pressure
Without sufficient glutathione, the liver may struggle to process the environmental stressors we encounter daily
Using either compound alone engages one pathway
Phytic acid as a potential treatment for Alzheimer's pathology: evidence from animal and in vitro models